冠状动脉CT血管成像衍生血流储备分数的预后价值:系统综述与荟萃分析
该系统综述与荟萃分析纳入5项研究共5460例稳定性冠心病患者,评估FFRCT检测的预后价值。12个月随访中,主要终点(全因死亡或心肌梗死)在FFRCT>0.80组发生率为0.6%(13/2126),FFRCT≤0.80组为1.4%(47/3334),相对风险2.31(95%CI 1.29-4.13,p=0.005)。FFRCT每降低0.10单位,主要终点风险增加(RR 1.67,95%CI 1.47-1.87,p<0.001)。
要点
- FFRCT>0.80(阴性)患者12个月事件率低,预后较好。
- FFRCT≤0.80(阳性)患者主要终点风险是阴性组的2.31倍。
- FFRCT数值每降低0.10,主要终点风险增加67%。
核心结论
- 稳定性冠心病患者中,FFRCT阴性结果者12个月事件率低,且阴性者不良结局风险低于阳性者。
- FFRCT数值与结局呈负相关,每降低0.10单位主要终点风险增加(RR 1.67,95%CI 1.47-1.87,p<0.001)。
研究设计与样本
- 系统综述与协作荟萃分析,检索PubMed和Web of Science数据库2010年1月1日至2020年12月31日发表的评估FFRCT检测后临床结局的研究。
- 共纳入5项研究,总计5460例稳定性冠心病患者符合荟萃分析条件。
主要发现
- 主要终点(全因死亡或心肌梗死)发生于60例(1.1%)患者,其中FFRCT>0.80组0.6%(13/2126),FFRCT≤0.80组1.4%(47/3334),RR 2.31(95%CI 1.29-4.13),p=0.005。
- MACE、心肌梗死、自发性心肌梗死或非计划血运重建在FFRCT≤0.80组均较FFRCT>0.80组更常见。
- FFRCT每降低0.10单位与主要终点风险增加相关(RR 1.67,95%CI 1.47-1.87,p<0.001)。
临床怎么用
- 对于稳定性冠心病患者,FFRCT>0.80提示12个月不良事件风险低,可支持保守管理决策。
- FFRCT≤0.80与更高的事件风险相关,应加强临床关注和随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To obtain more powerful assessment of the prognostic value of fractional flow reserveCT testing we performed a systematic literature review and collaborative meta-analysis of studies that assessed clinical outcomes of CT-derived calculation of FFR (FFRCT) (HeartFlow) analysis in patients with stable coronary artery disease (CAD). METHODS: We searched PubMed and Web of Science electronic databases for published studies that evaluated clinical outcomes following fractional flow reserveCT testing between 1 January 2010 and 31 December 2020. The primary endpoint was defined as 'all-cause mortality (ACM) or myocardial infarction (MI)' at 12-month follow-up. Exploratory analyses were performed using major adverse cardiovascular events (MACEs, ACM+MI+unplanned revascularisation), ACM, MI, spontaneous MI or unplanned (>3 months) revascularisation as the endpoint. RESULTS: Five studies were identified including a total of 5460 patients eligible for meta-analyses. The primary endpoint occurred in 60 (1.1%) patients, 0.6% (13/2126) with FFRCT>0.80% and 1.4% (47/3334) with FFRCT ≤0.80 (relative risk (RR) 2.31 (95% CI 1.29 to 4.13), p=0.005). Likewise, MACE, MI, spontaneous MI or unplanned revascularisation occurred more frequently in patients with FFRCT ≤0.80 versus patients with FFRCT >0.80. Each 0.10-unit FFRCT reduction was associated with a greater risk of the primary endpoint (RR 1.67 (95% CI 1.47 to 1.87), p<0.001). CONCLUSIONS: The 12-month outcomes in patients with stable CAD show low rates of events in those with a negative FFRCT result, and lower risk of an unfavourable outcome in patients with a negative test result compared with patients with a positive test result. Moreover, the FFRCT numerical value was inversely associated with outcomes.
引用
- Nørgaard BL, Gaur S, Fairbairn TA, et al. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. Heart. 2021. PMID: 34686567. doi:10.1136/heartjnl-2021-319773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。